Steroid-Sparing Therapy for Tyrosine Kinase Inhibitor–Induced Pneumonitis

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.11.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tyrosine Kinase Inhibitor and Target Therapy

2013English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer

Experimental & Molecular Medicine
2016English

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

Blood Cancer Journal
OncologyHematology
2012English

Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

Cancer
Cancer ResearchOncology
2010English

P3.cr-14 a Case of EGFR Tyrosine Kinase Inhibitor (TKI), Osimertinib Induced Pneumonitis in a Patient With Recurrent Fevers of Unknown Origin

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Stochastic Modelling of Tyrosine Kinase Inhibitor Rotation Therapy in Chronic Myeloid Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Analysis of Onset Mechanism for Tyrosine Kinase Inhibitor Imatinib Induced-Left Ventricular Diastolic Dysfunction

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

A Specific Inhibitor for Tyrosine Protein Kinase From Pseudomonas.

Journal of Antibiotics
Drug DiscoveryPharmacology
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy